Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-PS-22-004: Understanding HIV/STD Risk and Enhancing PrEP Implementation Messaging in a Diverse Community-Based Sample of Gay, Bisexual, and Other Men Who Have Sex with Men in a Transformational Era

Closed Closed January 18, 2022 Opportunity RFA-PS-22-004 ☆ Save

This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2021.

• Award ceiling$1.5 million
• Award floor$1.4 million
• Total funding$5.9 million
• Expected awards1
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments and tribes.

The following types of Higher Education Institutions are always encouraged to apply for CDC support as Non-profit Public or Non-profit Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits (Other than Institutions of Higher Education) Private Non-profit Institutions of Higher Education Eligible Agencies of the Federal Government Faith-based or Community-based Organizations U.S. Territory or Possession Regional Organizations Bona Fide Agents: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms." Federally Funded Research and Development Centers (FFRDCs): FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not-for-profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long-term research or development need which cannot be met as effectively by an agency’s existing in-house or contractor resources. FFRDC’s enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to https://gov.ecfr.io/cgi-bin/searchECFR

More grants for nonprofits, colleges and universities, state and local governments, tribes.

Is this a realistic fit?

• Past Prevention of Disease, Disability, and Death by Infectious Diseases awards averaged $1.9 million; this notice allows up to $1.5 million per award.
• No cost sharing or match is required.

What the grant funds

This NOFO supports research on HIV/STD risk and prevention behavior in an era when new pre-exposure prophylaxis (PrEP) methods are becoming available for a diverse community-based sample of gay, bisexual, and other men who have sex with men (MSM). The aim is to study PrEP use and other HIV/STD prevention behaviors over time among MSM in three (3) regions of the US, one of which should include the US South. The study should also serve to develop and test (quantitatively and qualitatively) brief PrEP and other HIV/STD prevention messaging to enhance protective behaviors among MSM. All MSM should receive alternating quarterly HIV and STD tests (i.e., an HIV test in one quarter, an STD test in the next quarter) and referral to prevention and treatment care, as requested or needed. Rapid reports should be provided following each wave of data collection to identify community trends and implications for prevention messaging. It is anticipated that this NOFO will support one multisite cooperative agreement award that covers three (3) research sites. The research sites should be priority jurisdictions outlined in Ending the HIV Epidemic in the United States (EHE), in support of the goals of EHE and the National Strategic Plan, and other federal prevention planning efforts.

Category: Health.

Applying now

This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.